HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endocrine disruptors

This article was originally published in The Rose Sheet

Executive Summary

Hair care products containing human placenta and endocrine-disrupting compounds were advertised significantly more often in African-American-targeted magazines such as Essence and Ebony than in other women's publications, researchers at Silent Spring Institute state in study released Nov. 1. The study reviewed 8,000 magazine personal care product ads published between 1950 and 1994, which researchers allege might affect "risk of breast cancer or other health problems." Such products were advertised 70 times in sample Essence/Ebony issues and only twice in Mademoiselle. Recent findings have linked placenta- and hormone-infused products with the development of secondary sexual characteristics in African-American girls (1"The Rose Sheet," Feb. 15, 1999, p. 14)
Advertisement

Related Content

FDA Chemical Sensitivity Toxicology Clinicals Suggested By Coalition
FDA Chemical Sensitivity Toxicology Clinicals Suggested By Coalition
Advertisement
UsernamePublicRestriction

Register

RS008625

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel